BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3906050)

  • 1. Chemotherapy plus immunotherapy for patients with primary and metastatic brain tumors.
    Knerich R; Robustelli della Cuna G; Butti G; Pavesi L; Adinolfi D; Preti P; Locatelli D
    J Neurosurg Sci; 1985; 29(1):19-24. PubMed ID: 3906050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunobiology of primary intracranial tumors.
    Mahaley MS; Gentry RE; Bigner DD
    J Neurosurg; 1977 Jul; 47(1):35-43. PubMed ID: 194022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radio-chemo-immunotherapy (CCNU plus levamisole) for treatment of metastatic brain tumors. A pilot study.
    Robustelli della Cuna G; Pavesi L; Knerich R; Preti P; Paoletti P
    J Neurooncol; 1984; 2(3):237-40. PubMed ID: 6334142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response of disseminated breast cancer to combined modality treatment with chemotherapy and levamisole with or without Bacillus Calmette-Guérin.
    Hortobagyi GN; Yap HY; Blumenschein GR; Gutterman JU; Buzdar AU; Tashima CK; Hersh EM
    Cancer Treat Rep; 1978 Nov; 62(11):1685-92. PubMed ID: 728894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled study with BCNU vs. CCNU as adjuvant chemotherapy following surgery plus radiotherapy for glioblastoma multiforme.
    Solero CL; Monfardini S; Brambilla C; Vaghi A; Valagussa P; Morello G; Bonadonna G
    Cancer Clin Trials; 1979; 2(1):43-8. PubMed ID: 229983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New therapeutic approaches to treatment of malignant gliomas: chemotherapy and immunotherapy.
    Mahaley MS; Gillespie GY
    Clin Neurosurg; 1983; 31():456-69. PubMed ID: 6680086
    [No Abstract]   [Full Text] [Related]  

  • 7. Preliminary results of combined surgery and adjuvant Bacillus Calmette-Guérin plus levamisole treatment of resectable lung cancer.
    Wright PW; Hill LD; Peterson AV; Pinkham R; Johnson L; Ivey T; Bernstein I; Bagley C; Anderson R
    Cancer Treat Rep; 1978 Nov; 62(11):1671-5. PubMed ID: 215304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidisciplinary treatment for central nervous system tumours with nitrosourea compounds.
    Paoletti P; Robustelli della Cuna G; Knerich R; Strada MR
    Acta Neurochir (Wien); 1978; 41(4):287-99. PubMed ID: 356524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunobiology of primary intracranial tumors. Part 4: levamisole as an immune stimulant in patients and in the ASV glioma model.
    Mahaley MS; Steinbok P; Aronin P; Dudka L; Zinn D
    J Neurosurg; 1981 Feb; 54(2):220-7. PubMed ID: 6256510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of neuroectodermal brain tumors.
    Shapiro WR
    Ann Neurol; 1982 Sep; 12(3):231-7. PubMed ID: 6753729
    [No Abstract]   [Full Text] [Related]  

  • 11. [Chemotherapy of brain tumors].
    García del Muro Solans J; Martí Massó JF
    Neurologia; 1988; 3(1):19-25. PubMed ID: 3078754
    [No Abstract]   [Full Text] [Related]  

  • 12. Perioperative carmustine chemotherapy for malignant brain tumors.
    Butti G; Knerich R; Tanghetti B; Adinolfi D; Gaetani P; Buoncristiani P; Paoletti P
    Cancer Treat Rep; 1984 Dec; 68(12):1505-6. PubMed ID: 6391664
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunotherapy from malignant disease.
    Goodnight JE; Morton DL
    Annu Rev Med; 1978; 29():231-83. PubMed ID: 348035
    [No Abstract]   [Full Text] [Related]  

  • 14. BCG, levamisole and transfer factor in the treatment of cancer.
    Spitler LE
    Prog Exp Tumor Res; 1980; 25():178-92. PubMed ID: 6986631
    [No Abstract]   [Full Text] [Related]  

  • 15. Chemoimmunotherapy of metastatic large bowel cancer: nonspecific stimulation with BCG and levamisole.
    Valdivieso M; Bedikian A; Burgess MA; Rodriguez V; Hersh EM; Bodey GP; Mavligit GM
    Cancer; 1977 Nov; 40(5 Suppl):2731-9. PubMed ID: 336190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combined postoperative therapy of glial brain tumors. Initial results of the pilot study].
    Schulz U; Bamberg M; Lapukins Z
    Strahlentherapie Sonderb; 1978; 75():166-70. PubMed ID: 400197
    [No Abstract]   [Full Text] [Related]  

  • 17. Surgical adjuvant immunotherapy for lung cancer: a review.
    Takita H
    Curr Surg; 1984; 41(4):254-61. PubMed ID: 6383721
    [No Abstract]   [Full Text] [Related]  

  • 18. Survival response of malignant gliomas to radiotherapy with or without BCNU or methyl-CCNU chemotherapy at the University of Kentucky Medical Center.
    Chin HW; Young AB; Maruyama Y
    Cancer Treat Rep; 1981; 65(1-2):45-51. PubMed ID: 7013978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined-modality treatment of inoperable lung cancer (i.v. immunotherapy, chemotherapy, and radiotherapy).
    Robinson E; Haim N; Segal R; Veseley Z; Mekori T
    Cancer Treat Rep; 1985 Mar; 69(3):251-8. PubMed ID: 2983892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Brain Tumor Cooperative Group NIH Trial 87-01: a randomized comparison of surgery, external radiotherapy, and carmustine versus surgery, interstitial radiotherapy boost, external radiation therapy, and carmustine.
    Selker RG; Shapiro WR; Burger P; Blackwood MS; Arena VC; Gilder JC; Malkin MG; Mealey JJ; Neal JH; Olson J; Robertson JT; Barnett GH; Bloomfield S; Albright R; Hochberg FH; Hiesiger E; Green S;
    Neurosurgery; 2002 Aug; 51(2):343-55; discussion 355-7. PubMed ID: 12182772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.